| 000 | 01888 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514191336.0 | ||
| 264 | 0 | _c20040824 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2004.03.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOude Lashof, A M L | |
| 245 | 0 | 0 |
_aAn open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cJun 2004 |
||
| 300 |
_a1314-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCandida albicans |
| 650 | 0 | 4 | _aCandida glabrata |
| 650 | 0 | 4 |
_aCandidiasis, Oral _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluconazole _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aItraconazole _xadverse effects |
| 650 | 0 | 4 |
_aLiver _xphysiopathology |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xmicrobiology |
| 700 | 1 | _aDe Bock, R | |
| 700 | 1 | _aHerbrecht, R | |
| 700 | 1 | _ade Pauw, B E | |
| 700 | 1 | _aKrcmery, V | |
| 700 | 1 | _aAoun, M | |
| 700 | 1 | _aAkova, M | |
| 700 | 1 | _aCohen, J | |
| 700 | 1 | _aSiffnerová, H | |
| 700 | 1 | _aEgyed, M | |
| 700 | 1 | _aEllis, M | |
| 700 | 1 | _aMarinus, A | |
| 700 | 1 | _aSylvester, R | |
| 700 | 1 | _aKullberg, B J | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 40 _gno. 9 _gp. 1314-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2004.03.003 _zAvailable from publisher's website |
| 999 |
_c14885036 _d14885036 |
||